Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication.
about
Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesionsLong term proton pump inhibitor (PPI) use and incidence of gastric premalignant lesionsProton pump inhibitors and gastritisInflammation, atrophy, and gastric cancerPathogenesis of Helicobacter pylori infectionEffect of interlukin-1beta on proliferation of gastric epithelial cells in culture.Helicobacter pylori associated Asian enigma: Does diet deserve distinction?Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisalAcid suppressive drugs and gastric cancer: a meta-analysis of observational studies25 Years of Proton Pump Inhibitors: A Comprehensive Review.Interleukin-1 polymorphisms associated with increased risk of gastric cancerCurrent concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus ReportThe rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studiesHelicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole.GORD in adults.Review article: Helicobacter pylori and gastro-oesophageal reflux disease-clinical implications and management.Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H pylori testing alone in the management of dyspepsia.Dietary factors modulate Helicobacter-associated gastric cancer in rodent modelsPathobiology of Helicobacter pylori infectionHelicobacter pylori: therapeutic targets.Survey on repeat prescribing for acid suppression drugs in primary care in Cornwall and the Isles of Scilly.Gastro-oesophageal reflux disease and Helicobacter pylori: an intricate relationHost determinants of Helicobacter pylori infection and its clinical outcome.Long-term proton pump inhibitor use and gastrointestinal cancerDigestive system disorders: gastroesophageal reflux disease.Personal review: is profound acid inhibition safe?Management of Helicobacter pylori infection: gastroenterological and surgical perspectives.Gastroesophageal reflux disease in the older patient: presentation, treatment, and complications.Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology.H. pylori infection and reflux oesophagitis: a case-control studyAtrophic gastritis during long-term omeprazole therapy affects serum vitamin B12 levels.Helicobacter pylori and dyspepsia.Drugs, bugs, and esophageal pH profilesHelicobacter pylori modulation of gastric acid.Helicobacter pylori, proton pump inhibitors and gastroesophageal reflux diseaseReview article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors.Review article: the clinical influence of Helicobacter pylori in effective acid suppression-implications for the treatment of gastro-oesophageal reflux disease.Long-term proton pump inhibitor administration, H pylori and gastric cancer: lessons from the gerbil.Management of Helicobacter pylori infection in Latin America: a Delphi technique-based consensusReview article: is Helicobacter pylori status relevant in the management of GORD?
P2860
Q24187480-9C11A252-A111-44C7-AE1C-94378E608E5EQ24202377-AD8DED04-066B-4877-A670-340D78026D72Q24655315-DC30056F-4EAC-4A5D-A7C3-B1C0750AB83FQ24676709-20AF02BA-CACD-451E-BDC1-34F563A59A1FQ24679810-C8B38A77-9B94-4A20-BE61-8EEABC5BE63CQ24806556-C2922636-2CEC-4F6E-BD8C-D4C857748399Q26751763-D53393C5-4CC1-4FA1-9E80-77AF92923B4FQ27021198-9605D3E3-2FE2-4D6D-A2F5-75D78F7F1671Q27025101-E46F82FC-3AA9-4367-AB7E-51386A25E167Q28070003-A75D38AE-455E-4680-80D1-765F1FB922C6Q28140456-D11DAB0F-65B8-40AF-A932-25683C040558Q28203195-98DB4176-33E0-4E5F-979B-DCD7C78D93DBQ28344815-1EE17FB8-B3BF-4E5C-9662-8B1552EAA3E1Q31795222-B82C0777-48F0-4A8F-B79E-28BAD5CCF37DQ33446555-BFF09762-22A2-4AC0-A437-DE738D3ECA00Q33548205-B5368E29-2B56-440D-B340-70C7AC3A3293Q33619704-78602820-A547-4B5C-B1F1-7CA6E9EF4A17Q33621846-F57284E8-BE2B-4BEF-9A58-0D9BE8CC6D85Q33666956-7D1B5A66-086D-4485-AABA-1DA0E5ED743DQ33667006-94EF7753-46B3-422D-AAAF-DD8484CA38EEQ33670729-953B00A7-7CE6-4B33-A178-10C5E5D4695AQ33717334-CBBF9428-7FBB-4ACC-8134-B67C3560312EQ33723758-89614EA7-A350-4649-A291-471E098C9583Q33727006-976018CE-74B9-4FB8-B06F-4A074A6D513EQ33727870-F8AD227A-BB0D-4345-836A-292D04FA1855Q33815745-4BEF9BD5-3D1D-46D8-82F4-8117F1F2A347Q33840152-7E5D95F7-F9D9-4C79-900B-30A8AF2E0464Q33844276-F1610297-2445-4C32-A6CE-9760C0030729Q33864468-EBEBF99B-64A0-4329-84FE-4A6CEF0AD9AEQ33869224-F00ACCA5-BF62-4E75-A6F2-2C19F3A0C92AQ33878289-0BB794A7-2A48-485C-82C9-8EFE2E6DD5C4Q33898625-A138F855-61A8-479B-8EC4-4E7EC1D410D9Q33898635-AE0B0123-D7B0-4E55-8E84-1192B4B5E27DQ33898652-629E91D5-2712-4885-8470-1170037402F7Q33898661-99482E8B-5809-4706-A487-358876532B33Q33940198-8F052A86-4492-48B0-AB1D-0152A48EB7A6Q33994156-F021AECF-A7C4-4979-9778-9310A747017EQ34063782-FA0048E1-528E-4BC1-9C3F-42F1E6C2C1A9Q34067951-0836CD40-A72D-4FFA-927B-E722B0BB66DAQ34069835-EE33AD67-713E-437E-AFD5-1AECC87DBACA
P2860
Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication.
description
1996 nî lūn-bûn
@nan
1996 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Atrophic gastritis and Helicob ...... omeprazole or fundoplication.
@ast
Atrophic gastritis and Helicob ...... omeprazole or fundoplication.
@en
Atrophic gastritis and Helicob ...... omeprazole or fundoplication.
@nl
type
label
Atrophic gastritis and Helicob ...... omeprazole or fundoplication.
@ast
Atrophic gastritis and Helicob ...... omeprazole or fundoplication.
@en
Atrophic gastritis and Helicob ...... omeprazole or fundoplication.
@nl
prefLabel
Atrophic gastritis and Helicob ...... omeprazole or fundoplication.
@ast
Atrophic gastritis and Helicob ...... omeprazole or fundoplication.
@en
Atrophic gastritis and Helicob ...... omeprazole or fundoplication.
@nl
P2093
P1476
Atrophic gastritis and Helicob ...... omeprazole or fundoplication.
@en
P2093
Dalenback J
Klinkenberg-Knol EC
Kuipers EJ
Meuwissen SG
P304
P356
10.1056/NEJM199604183341603
P407
P577
1996-04-01T00:00:00Z